SEC Form 4 · accession 0001179110-17-005296
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paris Panayiotopoulos
Director
Period of report
Mar 28, 2017
Accepted (ET)
Mar 31, 2017 · 2:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Call Option (right-to-buy)F1 | $51.02 | Mar 28, 2017 | A | 16,559 | A | — | Mar 28, 2027 | Common Stock | 16,559 | 16,559 | D |
Explanation of responses
- F1This option vests in one installment on March 28, 2027 and is made part of and pursuant to Issuer's director compensation package.